A slide presentation relating to the call will be available via the webcast link on the PDL website at http://www.pdl.com/.
|
INCLINE VILLAGE, Nev., July 31, 2019 /PRNewswire/ -- PDL BioPharma Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it will release its second quarter 2019 financial results for the period ended June 30, 2019, on Wednesday, August 7, 2019, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern time to discuss the operating and financial results and recent developments. A slide presentation relating to the call will be available via the webcast link on the PDL website at http://www.pdl.com/.
Conference Call Details To access the live and subsequently archived webcast of the conference call, go to the Company's website and go to "Events & Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. About PDL BioPharma NOTE: PDL, PDL BioPharma, the PDL logo and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary, to PDL BioPharma, Inc. which reserves all rights therein.
SOURCE PDL BioPharma, Inc. |
||
Company Codes: NASDAQ-NMS:PDLI |
